Create a Report
Please provide report title
Please provide location
Please provide details
Get alerts and updates for your case!
This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.
Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Please accept our Terms & Conditions
Add photos or video
We recommend photos and videos to help explain your report
Add Photo/Video
Email or SMS copy of report
Enter below to get emailed a copy of your report, or sms a link to your report
Please provide email or phone
Please provide email or phone
Please accept our Terms & Conditions
Thank you for your report!


IMPORTANT - Your report is queued
It may take up to 12 hours to process your report.


Email us at support@safelyhq.com if you have questions.

Report by
Loading...
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

IBSA TIROSINT®-SOL (levothyroxine sodium) - recalled due to subpotency, USA

1 year ago

United States

IBSA Pharma Inc. is voluntarily recalling 27 lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution to the consumer level. This voluntary recall has been initiated because these lots may be subpotent. The company’s analyses show a slight decrease below 95.0% of its labeled amount in levothyroxine sodium (T4) for some lots. This recall does not apply to TIROSINT® (levothyroxine sodium) capsules. To date, IBSA Pharma Inc. has not received any reports of adverse events that have been determined to be related to this voluntary recall.

Risk Statement: Patients being treated for hypothyroidism (underactive thyroid), who receive subpotent TIROSINT®-SOL, may experience signs and symptoms of hypothyroidism (underactive thyroid) which may include, fatigue, increased sensitivity to cold, constipation, dry skin, puffy face, hair loss, slow heart rate, depression, swelling of the thyroid gland and/or unexplained weight gain or difficulty losing weight. Over- or under-treatment with TIROSINT® SOL may have negative effects on growth and development, cardiovascular function, bone metabolism, reproductive function, cognitive function, emotional state, gastrointestinal function, and glucose and lipid metabolism.

Any patients including those who might be pregnant, newborn infants, or elderly patients, should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

TIROSINT®-SOL is indicated for: Hypothyroidism - As replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism.

Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression - As an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well differentiated thyroid cancer.

TIROSINT®-SOL oral solution is a clear, colorless to slightly yellow solution supplied in a 1 mL white, non-transparent, unit-dose ampule. The dosage strength is identified on the box and the pouch, and is associated with a distinct color. Each ampule bears a colored label with the dosage strength and the product name (TIROSINT®-SOL). For full prescribing information, visit www.TirosintSOL.com.

The product description, NDC numbers, lot numbers, and expiration dates of affected TIROSINT® SOL lots are shown below:

- Product Description: TIROSINT-SOL 13 mcg/mL 30 units carton-box. NDC: 71858-0105-5. Lot Number: 220409. Expiration Date: 10/1/2023.
- Product Description: TIROSINT-SOL 13 mcg/mL 30 units carton-box. NDC: 71858-0105-5. Lot Number: 220956. Expiration Date: 3/1/2024.
- Product Description: TIROSINT-SOL 25 mcg/mL 30 units carton-box. NDC: 71858-0110-5. Lot Number: 220856. Expiration Date: 2/1/2024.
- Product Description: TIROSINT-SOL 37.5 mcg/mL 30 units carton-box. NDC: 71858-0112-5. Lot Number: 220552. Expiration Date: 11/1/2023.
- Product Description: TIROSINT-SOL 37.5 mcg/mL 30 units carton-box. NDC: 71858-0112-5. Lot Number: 221055. Expiration Date: 4/1/2024.
- Product Description: TIROSINT-SOL 44 mcg/mL 30 units carton-box. NDC: 71858-0113-5. Lot Number: 220553. Expiration Date: 11/1/2023.
- Product Description: TIROSINT-SOL 44 mcg/mL 30 units carton-box. NDC: 71858-0113-5. Lot Number: 221056. Expiration Date: 4/1/2024.
- Product Description: TIROSINT-SOL 50 mcg/mL 30 units carton-box. NDC: 71858-0115-5. Lot Number: 220407. Expiration Date: 10/1/2023.
- Product Description: TIROSINT-SOL 50 mcg/mL 30 units carton-box. NDC: 71858-0115-5. Lot Number: 220960. Expiration Date: 3/1/2024.
- Product Description: TIROSINT-SOL 62.5 mcg/mL 30 units carton-box. NDC: 71858-0117-5. Lot Number: 220556. Expiration Date: 11/1/2023.
- Product Description: TIROSINT-SOL 62.5 mcg/mL 30 units carton-box. NDC: 71858-0117-5. Lot Number: 221058. Expiration Date: 4/1/2024.
- Product Description: TIROSINT-SOL 75 mcg/mL 30 units carton-box. NDC: 71858-0120-5. Lot Number: 220853. Expiration Date: 2/1/2024.
- Product Description: TIROSINT-SOL 88 mcg/mL 30 units carton-box. NDC: 71858-0125-5. Lot Number: 220411. Expiration Date: 10/1/2023.
- Product Description: TIROSINT-SOL 88 mcg/mL 30 units carton-box. NDC: 71858-0125-5. Lot Number: 220854. Expiration Date: 2/1/2024.
- Product Description: TIROSINT-SOL 100 mcg/mL 30 units carton-box. NDC: 71858-0130-5. Lot Number: 220413. Expiration Date: 10/1/2023.
- Product Description: TIROSINT-SOL 100 mcg/mL 30 units carton-box. NDC: 71858-0130-5. Lot Number: 220964. Expiration Date: 3/1/2024.
- Product Description: TIROSINT-SOL 112 mcg/mL 30 units carton-box. NDC: 71858-0135-5. Lot Number: 220414. Expiration Date: 10/1/2023.
- Product Description: TIROSINT-SOL 112 mcg/mL 30 units carton-box. NDC: 71858-0135-5. Lot Number: 220852. Expiration Date: 2/1/2024.
- Product Description: TIROSINT-SOL 112 mcg/mL 30 units carton-box. NDC: 71858-0135-5. Lot Number: 220970. Expiration Date: 3/1/2024.
- Product Description: TIROSINT-SOL 125 mcg/mL 30 units carton-box. NDC: 71858-0140-5. Lot Number: 220855. Expiration Date: 2/1/2024.
- Product Description: TIROSINT-SOL 137 mcg/mL 30 units carton-box. NDC: 71858-0145-5. Lot Number: 220415. Expiration Date: 10/1/2023.
- Product Description: TIROSINT-SOL 137 mcg/mL 30 units carton-box. NDC: 71858-0145-5. Lot Number: 221052. Expiration Date: 4/1/2024.
- Product Description: TIROSINT-SOL 150 mcg/mL 30 units carton-box. NDC: 71858-0150-5. Lot Number: 220959. Expiration Date: 3/1/2024.
- Product Description: TIROSINT-SOL 175 mcg/mL 30 units carton-box. NDC: 71858-0155-5. Lot Number: 220416. Expiration Date: 10/1/2023.
- Product Description: TIROSINT-SOL 175 mcg/mL 30 units carton-box. NDC: 71858-0155-5. Lot Number: 221053. Expiration Date: 4/1/2024.
- Product Description: TIROSINT-SOL 200 mcg/mL 30 units carton-box. NDC: 71858-0160-5. Lot Number: 220418. Expiration Date: 10/1/2023.
- Product Description: TIROSINT-SOL 200 mcg/mL 30 units carton-box. NDC: 71858-0160-5. Lot Number: 220560. Expiration Date: 11/1/2023.

Patients who are currently taking TIROSINT®-SOL should not discontinue use without contacting their healthcare provider for further guidance and/or replacement prescription.

In case you experienced harm from these products, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance.

Company name: IBSA Pharma Inc.
Brand name: IBSA
Product recalled: TIROSINT®-SOL (levothyroxine sodium)
Reason of the recall: Subpotency
FDA Recall date: February 01, 2023

Source: fda.gov

303


Related Reports

Amneal Pharmaceuticals, LLC. Bridgewater, New Jersey (Amneal), is voluntarily recalling 4 lots (see table below) of Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL packaged in 80 mL, 150 mL, or 300 mL pack sizes, to the Consumer Level. Some bottles may have been overfilled which can... See More result in an over-potent dosing regimen. The affected Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL lots were distributed Nationwide in the USA directly to Wholesalers and Distributors. The Lots were distributed between 11/09/2023 and 2/20/2024. To date, Amneal has not received any reports of adverse events that have been confirmed to be directly related to this recall.

Risk Statement: Adult patients who are prescribed the maximum daily dose of up to 2 grams per day of Vancomycin Hydrochloride for oral solution, USP 250 mg/5mL, may receive up to 4 grams of oral vancomycin per day because of the overfilled bottle. Some patients with inflammatory disorders of the intestinal mucosa also may have significant systemic absorption of vancomycin. These patients may be at risk for the development of adverse reactions associated with higher doses of vancomycin oral solution. Worsening renal function could be associated with electrolyte abnormalities such as high potassium leading to cardiac arrest.

The recommended maximum daily dose allowance for this product is up to 2gm/day and patients prescribed a dosing regimen of 500 mg/10mL would exceed this daily allowance, which may be harmful to patients with renal insufficiency. The error occurred during the manual bottle filling stage of manufacturing.

Vancomycin Hydrochloride for Oral Solution, USP, 250mg/5mL, is administered orally for treatment of enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains) and antibiotic- associated pseudomembranous colitis caused by C. difficile.

The Vancomycin HCl for Oral Solution, USP, 250 mg/5mL subject to the recall, are identified by the NDC numbers stated on the product label. The following lot numbers of Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL are included in this recall.

Vancomycin Hydrochloride for Oral Solution, USP, 250mg/5mL.
- Pack Size: 80 mL, Expiration Date: 09/2025, Lot: 22613003A, NDC No.: 69238-2261-3.
- Pack Size: 150 mL, Expiration Date: 09/2025, Lot: 22613004A, NDC No.: 69238-2261-7.
- Pack Size: 150 mL, Expiration Date: 09/2025, Lot: 22613005A, NDC No.: 69238-2261-7.
- Pack Size: 300 mL, Expiration Date: 09/2025, Lot: 22613005B, NDC No.: 69238-2261-5.

Anyone with an existing inventory of the product being recalled should examine the product and quarantine any of the recalled lots immediately. Retailers who have Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL, which are being recalled, should examine their inventory and cease dispensing any of the impacted lots.

In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.

Company name: Amneal Pharmaceuticals, LLC.
Brand name: Amneal
Product recalled: Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL
Reason of the recall: Super potent due to bottles being overfilled
FDA Recall date: March 27, 2024

Source: fda.gov
See Less


Pyramid Wholesale is issuing a recall of various brands of products sold as dietary supplements for sexual enhancement because they contain undeclared prescription drugs including Sildenafil (Viagra) and/or Tadalafil (Cialis). There have been no reports of injury or illness, to date. They were sold in bulk to... See More other distributors and retailers in California and out of state.

These products have the potential to cause severe adverse health effects due to misuse, overuse, interaction with other medications, underlying health conditions, and overall lack of oversight or consultation with medical professionals.

The products were distributed under 11 different brand names and varied in product form and size. A full list is available in the link below. Consumers should immediately discontinue use of the product.

Company name: Pyramid Wholesale
Brand name: Various
Product recalled: Dietary supplements for sexual enhancement
Reason of the recall: Undeclared Sildenafil and/or Tadalafil
FDA Recall date: March 20, 2024

Source: fda.gov
See Less
288


Several brands of folic acid tablets have been recalled in Canada due to concerns that affected lots may exceed the acceptable intake limit for N-nitroso-folic acid. The recall involves multiple brands distributed across the country.

-Affected products
Brand: Compliments FOLIC ACID 1MG, Product Name: FOLIC ACID 1MG,... See More Market Authorization: NPN 00647039, Dosage Form: Tablet, Strength: Folate 1.0 mg, Lot numbers: 2G3115NHH
Brand: Equate FOLIC ACID 1MG, Product Name: FOLIC ACID 1MG, Market Authorization: NPN 00647039, Dosage Form: Tablet, Strength: Folate 1.0 mg, Lot numbers: 2G3115LRJ & 2G3115NHF
Brand: Health One FOLIC ACID 1MG, Product Name: FOLIC ACID 1MG, Market Authorization: NPN 00647039, Dosage Form: Tablet, Strength: Folate 1.0 mg, Lot numbers: 2G3115NJL
Brand: Nature's Bounty FOLIC ACID 1MG, Product Name: FOLIC ACID 1MG, Market Authorization: NPN 00647039, Dosage Form: Tablet, Strength: Folate 1.0 mg, Lot numbers: 2340T8130A
Brand: Pharmasave FOLIC ACID 1MG, Product Name: FOLIC ACID 1MG, Market Authorization: NPN 00647039, Dosage Form: Tablet, Strength: Folate 1.0 mg, Lot numbers: 2G3115NHG
Brand: Sisu FOLIC ACID 1MG, Product Name: FOLIC ACID 1MG, Market Authorization: NPN 00647039, Dosage Form: Tablet, Strength: Folate 1.0 mg, Lot numbers: 2G3115M1C

Consumers are advised to consult their healthcare provider if they have any health concerns related to this recall.

Return affected product to your local pharmacy or place of purchase. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.

If you or a loved one are harmed or experiencing any symptoms, it is important to report it. Reporting can help to detect & resolve outbreaks early and prevent others from being harmed, and enables better surveillance. If symptoms persist, seek medical care.

Source: recalls-rappels.canada.ca
See Less
84


Endo International plc announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), is voluntarily recalling one lot of Treprostinil Injection 20mg/20mL (1mg/mL) to the consumer level. The product is being recalled due to the potential for the presence of silicone particulates in the product... See More solution. The lot was distributed nationwide to wholesalers and hospitals from June 16, 2022, through October 17, 2022. To date, Par has not received any reports of adverse events related to this recall.

Administration of an injectable product that contains particulate matter may result in local irritation or swelling in response to the foreign material. If the particulate matter reaches the blood vessels it can travel to various organs and block blood vessels in the heart, lungs, or brain which can cause stroke and even lead to death.

Treprostinil Injection is formulated for subcutaneous or intravenous infusion. The product is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension to diminish symptoms associated with exercise and for patients who require a transition from epoprostenol to reduce the rate of clinical deterioration.

Treprostinil Injection 20mg/20mL (1mg/mL) is distributed in 20mL multidose vials as sterile solutions in water for injection, individually packaged in cartons under NDC #42023-206-01. Only Lot 57014, expiration date 04/2024 is affected by this recall. Vials from the affected lot bear the attached label.

Par is providing written notification to wholesale accounts and the hospital location that has received the affected lot and is arranging for the return of all existing inventory of Lot 57014 through Inmar, Inc. Wholesale distributors and hospital pharmacies that have the product being recalled should immediately discontinue the use and stop distribution immediately.

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.

Company name: Endo International, Par Pharmaceutical
Brand name: Par Pharmaceutical
Product recalled: Treprostinil 20mg/20mL Injection
Reason for the recall: Potential Presence of Silicone Particulate Matter
FDA Recall date: March 12, 2024

Source: fda.gov
See Less
303


Brassica Pharma Pvt. Ltd. is voluntarily recalling the Eye Ointment products listed below with expiration dates ranging from February 2024 to September 2025. The products are being recalled due to a lack of sterility assurance. These products were distributed nationwide to wholesalers, retailers, and via the product... See More distributors, Walmart, CVS, and AACE Pharmaceuticals Inc. To date, Brassica Pharma Pvt. Ltd. has not received any reports of adverse events up to 16th February 2024 related to this recall.

For those patients who use these products, there is a potential risk of eye infections or related harm. These products are intended to be sterile. Ophthalmic drug products pose a potentially heightened risk of harm to users because drugs applied to the eyes bypass some of the body’s natural defenses.

The affected products are:
- Product Name: Equate Lubricant Eye Ointment (Mineral Oil 42.5%, White Petrolatum 57.3%, Lanolin Alcohols), Package Description: 3.5-gram tube, packaged in a cardboard box, Brand Name: Equate, NDC: 79903-026-35, UPC Code: 681131395298.
- Product Name: Equate Stye Lubricant Eye Ointment (Mineral Oil 31.9%, White Petrolatum 57.7%, Microcrystalline Wax, Stearic Acid, Wheat Germ Oil), Package Description: 3.5-gram tube, packaged in a cardboard box, Brand Name: Equate, NDC: 79903-028-35, UPC Code: 681131395304.
- Product Name: CVS Health Lubricant Eye Ointment (Mineral Oil 31.9%, White Petrolatum 57.7%, Microcrystalline Wax, Stearic Acid Wheat Germ Oil, Package Description: 3.5-gram tube, packaged in a cardboard box, Brand Name: CVS Health, NDC: 76168-707-35, UPC Code: 050428634141.
- Product Name: Lubricant PM Ointment, Package Description: 3.5-gram tube, packaged in a cardboard box, Brand Name: AACE Pharmaceuticals, NDC: 71406-124-35, UPC Code: 371406124356.
For Lot number and expiry dates, you can visit the link below.

Brassica Pharma Pvt. Ltd. Is notifying its distributors AACE Pharmaceuticals Inc and its retailers Walmart and CVS. These distributors shall be further notifying the wholesalers and retailers via mail of this recall and arranging for return of all impacted products listed above. Consumers, distributors and retailers that have any product which is being recalled should cease distribution of the product. Consumers should stop using the recalled Eye Ointment and may return any of the above listed products to the place of purchase.

In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.

Company name: Brassica Pharma Pvt. Ltd.
Brand name: Multiple brands
Product recalled: Eye ointment products
Reason of the recall: Due to Potential Lack of Sterility Assurance.
FDA Recall date: February 26, 2024

Source: fda.gov
See Less
303


According to The Public Service Company of Oklahoma, a power outage in north Tulsa on March 28 affected more than 15,000 customers after a transmission line equipment failure. Crews worked to fix the issue. Power was restored at about 2:00 p.m.

Outage link: d3k342lst4pmzf.cloudfront.net
Source: kjrh.com
Published:... See More 2024-03-28 See Less


A power outage was reported in Lawrence, Massachusetts after a car crash toppled utility poles and cast an entire neighborhood into darkness. The incident occurred on Myrtle Street near the intersection with Lawrence Street. According to the National Grid outage map, power has been restored to the... See More area.

Outage link: outagemap.ma.nationalgridus.com
Source: hoodline.com
Published: 2024-03-28
See Less


A power outage impacted customers in the Greeley-Evans District School District 6 area in Weld County on Thursday morning, Mar 28. According to Xcel Energy's outage map, power has been restored to the area.

Outage link: outagemap-xcelenergy.com
Source: greeleytribune.com
Published: 2024-03-28 See Less


A Walmart in southeast Missouri was closed due to a power outage. According to a post on the Poplar Bluff Walmart social media page, the location is closed until further notice. According to the outage map, power was restored to the area.

Outage link: ebill.ozarkborder.org
Source: kfvs12.com ... See More
Published: 2024-03-28
See Less


There were reports of a power outage in Charlotte. Duke Energy reported about 460 customers without electricity in the Sardis Woods area in Charlotte on Thursday afternoon, Mar 28. The outage started at 2:42 p.m. The estimated time for restoration is 6:30 p.m. The outage was caused... See More by an object coming into contact with power lines. Crews are working to safely restore power to the area.

Outage link: outagemap.duke-energy.com
Source: duke-energy.com
Published: 2024-03-28
See Less


Recent Interesting Reports

I received an ad on my phone for rechargeable tesla coil lighters that said it required no butane. So I ordered 4 so as to give as gifts. After entering all my info and chose to use pay pal I pressed the blue icon that said pay... See More now but a new window came up saying wait you're not finished and tried to sell me mire products. I was not interested so pressed the back arrow to get out of that page I then went to place order and it then ran through the order but instead of four it doubled the order. I immediately contacted pay pal within 4 minutes of purchase to cancel and the said they were putting in for a cancelation but the scammer company said that they had already been shipped. This was within 5 minutes of the order being placed. So I received them today and they are cheap butane lighters from China and NOT what were as advertised. NOT TESLA COIL LIGHTERS .. BEWARE OF THESE SCAMMERS ! I see these exact lighters advertised for $10.00 less than what I paid for these from this crooked company. I am concerned that if I send them back that I will never see them or my money back ! The address is Tach 1 (US) 192-01 Northern blvd Flushing , NY.11358
Beware !
See Less
1.4K


I received a package with an electric brush that I did not even order, but having several parcels to receive on the route I did not know what or what it was and so I was overwhelmed by the amount of 170 lei!!!!! Someone may be aware... See More of the reports they are making.

Considering that the package has been paid for and the fact that there is no way to be contacted, says a lot, EXCROCI! As far as I can see, others are deceived, the only solution is orders, and then rejected for payment!
See Less
51


I ordered two we nfl championship belts never received them, I would like to have my merchandise or be refunded!!!! See Less
227


Took money Dec. 19 2023 for Milwaukee tools.
Also listed modaked. com as a sponsor
Tried to contact them and got an error message See Less
18


You order a product and send you other non-compliant products.
I ordered a sweatshirt and received a children's greek from LINGXIA HONGKONG See Less
3


My PAYPAL was charged without me knowing, but sent an email to Keto something or other to refund $$ & they did without hesitation, but sent the product to me anyways. Haven't researched enough or tried the supplement. Just want this informoration out there incase its useful to anyone. See Less
47


I ordered a neck excercise
Which l received last week.
I just received the exact same excercise from a different address..the one l listed above..
I was charged for this second excercise which l did not order... See Less
1.0K


Did not order this ring it showed up in the mail box. I’m seeing on line this is a scam. Came from Second Brother, Flushing, NY See Less
8


Received a package and tried to call the number and they answered in Spanish and when i asked where I was calling they hung up on me See Less
1.1K


Last 30 days